Relation of serum uric acid with metabolic risk factors in asymptomatic middle-aged Brazilian men

被引:19
作者
Desai, MY
Santos, RD
Dalal, D
Carvalho, JAM
Martin, DR
Flynn, JA
Nasir, K
Blumenthal, RS
机构
[1] Johns Hopkins Univ, Sch Med, Ciccarone Prevent Cardiol Ctr, Dept Med & Rheumatol, Baltimore, MD 21287 USA
[2] Albert Einstein Hosp, Prevent Med Ctr, Sao Paulo, Brazil
[3] Univ Sao Paulo, Med Sch Hosp, Incor, Sao Paulo, Brazil
关键词
D O I
10.1016/j.amjcard.2004.12.013
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
This study in 352 asymptomatic middle-aged Brazilian men demonstrated that serum uric acid increases linearly with an increasing number (0 to >= 3) of metabolic risk factors (5.78 +/- 1.1, 6.14 +/- 1.0, 6.27 +/- 1. 1, and 6.79 +/- 1.3, p < 0.001). In patients who had >= 3 metabolic risk factors, there was a higher prevalence of serum uric acid in the highest quartile (7.2 to 10.3 mg/dl) than in the lowest quartile (2.6 to 5.4 mg/dl, 35% vs 12%, p < 0.001). Mean serum levels of uric acid were higher in those who had an abnormal ratio of >= 3 for triglyceride to high-density lipoprotein (suggesting insulin resistance) than in those who had a normal ratio (6.6 +/- 1.2 vs 5.87 +/- 1 mg/dl, p < 0.001). (c) 2005 by Excerpta Medica Inc.
引用
收藏
页码:865 / 868
页数:4
相关论文
共 20 条
  • [1] Uric acid: role in cardiovascular disease and effects of losartan
    Alderman, M
    Aiyer, KJV
    [J]. CURRENT MEDICAL RESEARCH AND OPINION, 2004, 20 (03) : 369 - 379
  • [2] Pathogenesis and treatment of kidney disease and hypertension - Effect of statins versus untreated dyslipidemia on serum uric acid levels in patients with coronary heart disease: A subgroup analysis of the GREek Atorvastatin and Coronary-heart-disease Evaluation (GREACE) study
    Athyros, VG
    Elisaf, M
    Papageorgiou, AA
    Symeonidis, AN
    Pehlivanidis, AN
    Bouloukos, VI
    Milionis, HJ
    Mikhailidis, DP
    [J]. AMERICAN JOURNAL OF KIDNEY DISEASES, 2004, 43 (04) : 589 - 599
  • [3] BECKER BF, 1991, CHEST, V100, P176
  • [4] Prevalence of hyperuricemia and relation of serum uric acid with cardiovascular risk factors in a developing country
    Conen, D
    Wietlisbach, V
    Bovet, P
    Shamlaye, C
    Riesen, W
    Paccaud, F
    Burnier, M
    [J]. BMC PUBLIC HEALTH, 2004, 4 (1) : 1 - 9
  • [5] Hypothesis: Uric acid, nephron number, and the pathogenesis of essential hypertension
    Feig, DI
    Nakagawa, T
    Karumanchi, SA
    Oliver, WJ
    Kang, DH
    Finch, J
    Johnson, RJ
    [J]. KIDNEY INTERNATIONAL, 2004, 66 (01) : 281 - 287
  • [6] RELATION OF BODY FATNESS AND ITS DISTRIBUTION TO CARDIOVASCULAR RISK-FACTORS IN YOUNG BLACKS AND WHITES - THE ROLE OF INSULIN
    FOLSOM, AR
    BURKE, GL
    BALLEW, C
    JACOBS, DR
    HASKELL, WL
    DONAHUE, RP
    LIU, K
    HILNER, JE
    [J]. AMERICAN JOURNAL OF EPIDEMIOLOGY, 1989, 130 (05) : 911 - 924
  • [7] Varying body mass index cutoff points to describe overweight prevalence among US Adults: NHANES III (1988 to 1994)
    Kuczmarski, RJ
    Carroll, MD
    Flegal, KM
    Troiano, RP
    [J]. OBESITY RESEARCH, 1997, 5 (06): : 542 - 548
  • [8] URIC-ACID AND CORONARY HEART-DISEASE RISK - EVIDENCE FOR A ROLE OF URIC-ACID IN THE OBESITY-INSULIN RESISTANCE SYNDROME
    LEE, J
    SPARROW, D
    VOKONAS, PS
    LANDSBERG, L
    WEISS, ST
    [J]. AMERICAN JOURNAL OF EPIDEMIOLOGY, 1995, 142 (03) : 288 - 294
  • [9] McLaughlin T, 2003, ANN INTERN MED, V139, P802, DOI 10.7326/0003-4819-139-10-200311180-00007
  • [10] Differences in insulin resistance do not predict weight loss in response to hypocaloric diets in healthy obese women
    McLaughlin, T
    Abbasi, F
    Carantoni, M
    Schaaf, P
    Reaven, G
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1999, 84 (02) : 578 - 581